homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

February 18, 2010

IsoRay

Richland-based IsoRay hired William Cavanagh as vice president of research and development for IsoRay Medical. Cavanagh was chief scientific officer for Sangretech Biomedical for six years, overseeing design and use of a novel cancer therapy. IsoRay is a medical isotope company focusing on the treatment of prostate cancer and other malignant diseases.




Email or user name:
Password:
 
Forgot password? Click here.